BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2932100)

  • 1. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
    Chapman HA; Stone OL
    Biochem J; 1985 Aug; 230(1):109-16. PubMed ID: 2932100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet release protein which inhibits plasminogen activators.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1985 Jul; 38(7):825-30. PubMed ID: 3926830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
    Wun TC; Reich E
    J Biol Chem; 1987 Mar; 262(8):3646-53. PubMed ID: 3102492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of plasminogen activator inhibitor by cultured human epidermal cells.
    Hashimoto K; Nishioka K; Katayama I; Yoshikawa K
    Br J Dermatol; 1986 Aug; 115(2):133-8. PubMed ID: 3091060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fibrinolytic inhibitor of human alveolar macrophages. Induction with endotoxin.
    Chapman HA; Stone OL
    Am Rev Respir Dis; 1985 Sep; 132(3):569-75. PubMed ID: 3898943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of the inhibition by plasminogen activator inhibitor 2 of urokinase isolated from human urine and recombinant microorganisms. Further evidence for correct tertiary structure of recombinant urokinase.
    Cramer J; Steffens G; Günzler WA; Hess V; Flohé L
    Arzneimittelforschung; 1988 Aug; 38(8):1196-8. PubMed ID: 3143371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
    Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
    J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.
    Crutchley DJ; Conanan LB
    J Biol Chem; 1986 Jan; 261(1):154-9. PubMed ID: 3079753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A direct, plasmin-independent assay for plasminogen activator.
    Mussoni L; Lawrence D; Loskutoff DJ
    Thromb Res; 1984 May; 34(3):241-54. PubMed ID: 6233750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.
    Christensen U; Holmberg L; Bladh B; Astedt B
    Thromb Haemost; 1982 Aug; 48(1):24-6. PubMed ID: 6813991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase binds to a plasminogen activator inhibitor type-2-like molecule in placental microvillous membranes.
    Jensen PH; Nykjaer A; Andreasen PA; Lund LR; Astedt B; Lecander I; Gliemann J
    Biochim Biophys Acta; 1989 Nov; 986(1):135-40. PubMed ID: 2819091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I; Thorsen S; Müllertz S
    Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking of the fibrinolytic antiactivator by substituted benzoates.
    Nanninga L; Guest M
    Life Sci; 1974 Jun; 14(12):2507-11. PubMed ID: 4283613
    [No Abstract]   [Full Text] [Related]  

  • 17. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
    Booth NA; Anderson JA; Bennett B
    Thromb Res; 1985 May; 38(3):261-7. PubMed ID: 3161209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.
    Chapman HA; Vavrin Z; Hibbs JB
    Cell; 1982 Mar; 28(3):653-62. PubMed ID: 6210439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells.
    Grant AJ; Ramshaw IA; Badenoch-Jones P; Eichner RD; Hunt NH
    Eur J Biochem; 1986 Feb; 154(3):635-41. PubMed ID: 3081343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells.
    Coleman PL; Patel PD; Cwikel BJ; Rafferty UM; Sznycer-Laszuk R; Gelehrter TD
    J Biol Chem; 1986 Mar; 261(9):4352-7. PubMed ID: 2936742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.